Massachusetts Financial Services Portfolio holdings
Massachusetts Financial Services (MFS), founded in 1924 and headquartered in Boston, Massachusetts, is a pioneering investment management firm credited with launching the first U.S. mutual fund, the Massachusetts Investors Trust. Managing hundreds of billions in assets, MFS offers a wide range of actively managed investment products, including equity, fixed-income, and balanced funds, serving institutional investors, financial advisors, and individuals globally. Known for its disciplined, research-driven approach, the firm emphasizes long-term value creation through fundamental analysis and a collaborative team structure, avoiding short-term market trends. With a legacy of innovation and a strong global presence, MFS remains a respected name in the asset management industry, balancing tradition with a focus on sustainable, client-centric investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$1.27B |
| 2 |
Progressive
PGR
|
+$755M |
| 3 |
Morgan Stanley
MS
|
+$692M |
| 4 |
Icon
ICLR
|
+$477M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$445M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$909M |
| 2 |
State Street
STT
|
+$714M |
| 3 |
Alibaba
BABA
|
+$609M |
| 4 |
Accenture
ACN
|
+$541M |
| 5 |
Goldman Sachs
GS
|
+$457M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.42% |
| 2 | Financials | 18.39% |
| 3 | Healthcare | 14.91% |
| 4 | Industrials | 13.45% |
| 5 | Communication Services | 8.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Fastenal
FAST
$58.3B
| $1.14M | ﹤0.01% |
45,414
+124
| +0.3% | +$2.97K |
|
827
CBRE Group
CBRE
$42.7B
| $1.14M | ﹤0.01% |
+14,407
| New | +$1.02M |
|
828
Telefônica Brasil
VIV
$19.3B
| $1.13M | ﹤0.01% |
143,840
-122,370
| -46% | -$1.02M |
|
829
Banco Macro
BMA
$5.51B
| $1.11M | ﹤0.01% |
83,322
+27,677
| +50% | +$391K |
|
|
CBAY
830
DELISTED
Cymabay Therapeutics
CBAY
| $1.08M | ﹤0.01% |
238,824
+91,471
| +62% | +$492K |
|
831
Accuray
ARAY
$33.8M
| $1.04M | ﹤0.01% |
+210,142
| New | +$1.08M |
|
832
Vir Biotechnology
VIR
$1.48B
| $1.03M | ﹤0.01% |
20,152
-33,335
| -62% | -$1.8M |
|
833
RBC Bearings
RBC
$17.9B
| $1.03M | ﹤0.01% |
+5,246
| New | +$987K |
|
|
RDUS
834
DELISTED
Radius Health, Inc.
RDUS
| $1.03M | ﹤0.01% |
49,366
-5,850
| -11% | -$123K |
|
|
ZYXI
835
DELISTED
Zynex
ZYXI
| $999K | ﹤0.01% |
71,980
-39,908
| -36% | -$609K |
|
836
RPM International
RPM
$14.8B
| $977K | ﹤0.01% |
10,634
+5,831
| +121% | +$504K |
|
837
AT&T
T
$162B
| $977K | ﹤0.01% |
42,747
-1,140
| -3% | -$25.2K |
|
|
CWEN.A
838
DELISTED
Clearway Energy Class A
CWEN.A
| $968K | ﹤0.01% |
36,505
-108,630
| -75% | -$3.14M |
|
839
OraSure Technologies
OSUR
$275M
| $959K | ﹤0.01% |
82,204
-9,741
| -11% | -$119K |
|
840
Arrow Electronics
ARW
$11.4B
| $953K | ﹤0.01% |
8,596
-256
| -3% | -$26.6K |
|
|
GTHX
841
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $952K | ﹤0.01% |
39,576
-15,332
| -28% | -$356K |
|
|
KRA
842
DELISTED
Kraton Corporation
KRA
| $941K | ﹤0.01% |
25,711
-8,641
| -25% | -$309K |
|
|
CLVS
843
DELISTED
Clovis Oncology, Inc.
CLVS
| $903K | ﹤0.01% |
128,656
-15,247
| -11% | -$102K |
|
844
PTC
PTC
$16B
| $900K | ﹤0.01% |
6,532
+3,244
| +99% | +$432K |
|
845
Baker Hughes
BKR
$62.3B
| $894K | ﹤0.01% |
+41,407
| New | +$943K |
|
846
Orthofix Medical
OFIX
$432M
| $894K | ﹤0.01% |
20,612
-2,441
| -11% | -$108K |
|
847
Antero Midstream
AM
$10.2B
| $883K | ﹤0.01% |
+97,806
| New | +$843K |
|
848
Lexicon Pharmaceuticals
LXRX
$1.05B
| $883K | ﹤0.01% |
+150,363
| New | +$1.04M |
|
|
SEE
849
DELISTED
Sealed Air
SEE
| $876K | ﹤0.01% |
19,116
+2,482
| +15% | +$111K |
|
850
Bristol-Myers Squibb
BMY
$131B
| $875K | ﹤0.01% |
+13,865
| New | +$863K |
|
Similar funds
Massachusetts Financial Services's Q1 2021 Portfolio in Review
As of Q1 2021, Massachusetts Financial Services held 992 positions worth $325B, up 4.4% from $311B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Massachusetts Financial Services's Q1 2021 filing shows 114 new, 357 increased, 433 reduced and 83 closed positions. Its largest new stake was Uber: 7,735,671 shares worth $422M. The largest sale was Zimmer Biomet, an estimated $909M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
- Massachusetts Financial Services's largest Q1 2021 buy was Uber: 7,735,671 shares worth $422M.
- Massachusetts Financial Services added most to Boston Scientific in Q1 2021, an estimated $1.27B increase.
- Massachusetts Financial Services's biggest Q1 2021 reduction was Zimmer Biomet, cutting an estimated $909M.
- Massachusetts Financial Services fully exited Baidu in Q1 2021, selling an estimated $203M.
- Massachusetts Financial Services's ten largest holdings make up 19% of its $325B portfolio in Q1 2021.
- Massachusetts Financial Services opened 114 new positions and closed 83 in Q1 2021.
- Massachusetts Financial Services's portfolio value rose 4.4% quarter-over-quarter to $325B.
Based on Massachusetts Financial Services's 13F filing for Q1 2021, filed 13 May 2021.